Head-to-head for women
REMEVi vs ShedRx
REMEVi and ShedRx both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
REMEVi
Higher scoreRanked #31 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViShedRx
Ranked #9 for women · Grade B
Luna Fit
Best for: Women who want an oral or sublingual option rather than weekly injections, at competitive tirzepatide pricing.
Visit ShedRxThe verdict for women
REMEVi edges out ShedRx on the Luna Fit Score, 85 to 83 (B vs B). Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. The reasoning behind that number is in the REMEVi scorecard.
ShedRx is still a genuine option — a weight-focused program that also offers an oral/sublingual route — a genuine relief for the needle-averse and for anyone easing in gradually. Weigh the six women's-health factors below against your own priorities; the ShedRx scorecard goes through each of them, and if neither of these two is the one, what women pick instead of ShedRx widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | REMEVi | ShedRx |
|---|---|---|
| Luna Fit Score | 85/100 · B | 83/100 · B |
| Overall rank | #31 | #9 |
| Semaglutide | $199/mo | $199/mo |
| Tirzepatide | $269/mo | $299/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Luna Fit
REMEVi
Ranked #31 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Luna Fit
ShedRx
Ranked #9 · Grade B
What we like
- Offers oral/sublingual forms — a real alternative to weekly shots
- Competitive tirzepatide pricing
- Weight-focused program with titration support
The caveats
- States-served not disclosed
- Compounded only
- Hormonal/PCOS framing is general, not specialized
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither REMEVi nor ShedRx is only worth comparing with the other. REMEVi is also written up against CoreAge Rx, 8 points apart on the Luna Fit Score — see the REMEVi–CoreAge Rx head-to-head. ShedRx is also written up against CoreAge Rx, 10 points apart — see the ShedRx–CoreAge Rx head-to-head.
- REMEVi vs CoreAge Rx
- REMEVi vs Enhance MD
- REMEVi vs yourEra
- ShedRx vs Sesame Care
- ShedRx vs HealthRX
- ShedRx vs MadeMed
Or browse the full comparison hub.